Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nippon Fine Chemical Co., Ltd. (4362.T)
Osaka, JP
Nippon Fine Chemical Co., Ltd., together with its subsidiaries, manufactures and sells fine chemical, cosmetic, and industrial chemical products in Japan and internationally. It operates through Industrial Products and Household Products segments. The company offers cosmetic ingredients for cosmetics and personal care products; natural oils and fats for pharmaceutical, cosmetic, industrial, and feed additive applications; and phospholipids used in pharmaceutical raw materials, presome, cholesterol, liposome, and other lipids. It also supplies fatty acid derivatives, such as acid chlorides, ß-ketoesters, and acid anhydrides to pharmaceuticals, functional resins, electronic materials, and various other industries; and manufactures and sells thermal and UV curable coating agents, and functional coatings. In addition, the company offers Neutron, a fatty acid amide; and rents real estate properties. The company was formerly known as Nippon Camphor Co., Ltd. and changed its name to Nippon Fine Chemical Co., Ltd. in 1971. Nippon Fine Chemical Co., Ltd. was incorporated in 1918 and is headquartered in Osaka, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.32% | -1.36% | -3.34% | -12.05% | -12.83% | -14.02% | +9.77% | -3.64% | +72.87% | +237.91% | +521.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-5.2% Q1'26: -1.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+17.6% ★ Q1'26: -4.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+15.5% ★ Q1'26: +16.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+9.9% ★ Q1'26: +9.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.7% ★ Q1'26: -3.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
36.84B
est: 37.30B (-1.2%)
|
33.53B
est: 33.10B (+1.3%)
|
35.66B
est: 35.70B (-0.1%)
|
34.40B
34.40B – 34.40B
-3.6% YoY
|
35.70B
35.70B – 35.70B
+3.8% YoY
|
36.90B
36.90B – 36.90B
+3.4% YoY
|
| EBITDA |
6.60B
est: 6.75B (-2.4%)
|
6.31B
est: 7.11B (-11.3%)
|
6.76B
est: 8.06B (-16.2%)
|
7.77B
7.77B – 7.77B
-3.6% YoY
|
8.06B
8.06B – 8.06B
+3.8% YoY
|
8.34B
8.34B – 8.34B
+3.4% YoY
|
| EBIT |
5.64B
est: 5.46B (+3.5%)
|
4.87B
est: 5.54B (-12.1%)
|
5.39B
est: 5.70B (-5.5%)
|
5.49B
5.49B – 5.49B
-3.6% YoY
|
5.70B
5.70B – 5.70B
+3.8% YoY
|
5.89B
5.89B – 5.89B
+3.4% YoY
|
| Net Income |
4.08B
est: 3.68B (+10.8%)
|
3.33B
est: 3.18B (+4.6%)
|
3.87B
est: 3.45B (+12.1%)
|
4.34B
4.34B – 4.34B
+25.7% YoY
|
4.54B
4.54B – 4.54B
+4.6% YoY
|
4.95B
4.95B – 4.95B
+8.9% YoY
|
| SGA |
4.89B
est: 5.36B (-8.8%)
|
4.72B
est: 4.76B (-0.7%)
|
5.98B
est: 5.33B (+12.2%)
|
5.14B
5.14B – 5.14B
-3.6% YoY
|
5.33B
5.33B – 5.33B
+3.8% YoY
|
5.51B
5.51B – 5.51B
+3.4% YoY
|
| EPS |
174.42
est: 163.70 (+6.5%)
|
146.40
est: 141.40 (+3.5%)
|
172.07
est: 157.80 (+9.0%)
|
198.30
198.30 – 198.30
+25.7% YoY
|
207.50
207.50 – 207.50
+4.6% YoY
|
226.00
226.00 – 226.00
+8.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 358.7K | 0.06% |
| 2 | Vanguard International Dividend Appreciation ETF VIGI | 0.00% | 454.2K | 0.07% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 574.7K | 0.06% |
| 4 | iShares Core TOPIX ETF 1475.T | 0.00% | 532.6K | 0.05% |
| 5 | Vanguard FTSE Pacific ETF VPL | 0.00% | 181.5K | 0.07% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.00% | 63.9K | 0.39% |
| 7 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 3.2K | 0.30% |
| 8 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 7.4K | 0.45% |
| 9 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 110.3K | 0.22% |
| 10 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 1.6K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiro Niimura | Senior Executive Officer and GM of the Administration Division & Accounting Department | — | — |
| Hiroshi Yano | Executive Officer, President, GM of Precision Chemical Business Hq. & Representative Director | — | male |
| Masaki Matsumoto | Senior Executive Officer | — | — |
| Masanobu Kawabayashi | Managing Executive Officer of Group Production Control & Plant Engineering Dept and Director | — | male |
| Susumu Yamasaki | Senior Executive Officer | — | — |
| Yukihiro Ohashi | Senior Exe Officer, GM of R&D Development & Research Institution and Director | — | male |
| Yutaka Iwamoto | Senior Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4362.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
